Iconic Therapeutics is a biopharmaceutical company built on scientific insight and expertise in Tissue Factor (TF) biology. We are pioneering a new class of TF-targeting molecules that target diseases in which this protein is overexpressed...
We have created a pipeline of therapeutic molecules for acute and chronic inflammation, ophthalmology and cancer...
We have a broad intellectual property portfolio that covers a set of anti-TF monoclonal antibodies that we have discovered in-house. Iconic also has an exclusive license from Yale University to an earlier anti-TF fusion protein.